2001
Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: Results from the Asthma Policy Model
Paltiel AD, Fuhlbrigge AL, Kitch BT, Liljas B, Weiss ST, Neumann PJ, Kuntz KM. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: Results from the Asthma Policy Model. Journal Of Allergy And Clinical Immunology 2001, 108: 39-in4. PMID: 11447380, DOI: 10.1067/mai.2001.116289.Peer-Reviewed Original ResearchConceptsSymptom-free daysCorticosteroid therapyAcute exacerbationModerate asthmaHealth-related qualityPopulation of patientsCost-effectiveness findingsHealth care costsCost-effectiveness analysisTotal health costsAdult asthmaObservational cohortRandomized trialsPatient preferencesPatient surveyClinical impactCorticosteroidsSide effectsCare costsDrug efficacyNatural historyAsthmaIncremental costTherapyMild
2000
Evaluation of Therapeutic Strategies: A New Method for Balancing Risk and Benefit
Troche C, Paltiel A, Makuch R. Evaluation of Therapeutic Strategies: A New Method for Balancing Risk and Benefit. Value In Health 2000, 3: 12-22. PMID: 16464177, DOI: 10.1046/j.1524-4733.2000.31002.x.Peer-Reviewed Original ResearchPatient preferencesDose-related efficacyPatients' subjective assessmentPatient-specific preferencesSpecific therapeutic interventionsClinical trial informationEfficacy-toxicity tradeDose prescribedSafety profileTherapeutic alternativeAcceptable efficacyDose intervalSubjective assessmentTherapeutic strategiesTherapeutic interventionsDrug efficacyDifferent patientsTrial informationDifferent drugsDose rangeEfficacyDifferent efficacyDrugsPatientsBalancing Risks